跳至主要内容
临床试验/NCT06251882
NCT06251882已完成不适用

6-month Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia

Peking University People's Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
visual analogue scale(VAS)

研究概览

简要总结

Meralgia paresthetica (MP) is one of the most common peripheral entrapment neuropathies of the lower limbs. It is characterized by paresthesia, pain, tingling, numbness, hypersensitivity, or other abnormal skin sensations on the anterolateral aspect of the thigh. The condition results from compression of the lateral femoral cutaneous nerve (LFCN) along its course, often occurring as the nerve exits the pelvis.The injection of 5% dextrose (D5W) under ultrasound guidance is a novel treatment method for peripheral nerve entrapment. However, there is limited evidence about the efficacy of this method for patients with MP. The investigators found D5W was more safe and effective than corticosteroids for patients with MP. Thus, this study aimed to evaluate the 6-month efficacy of ultrasound-guided injection of D5W for MP patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients aged between 18 and 80 years;
  • those diagnosed with MP based on clinical and physical examination, with symptoms persisting for at least 3 months;
  • a high-resolution ultrasound revealing LFCN compression as it exited the pelvis.

排除标准

  • MP resulting from trauma, surgery or occupying lesions affecting the LFCN;
  • pregnancy;
  • concurrent presence of rheumatic immune diseases, hypothyroidism, or diabetes mellitus;
  • a known history of allergy to lidocaine or corticosteroids;
  • L2/3 lumbar radiculopathy;
  • patients who had undergone local injection or surgery for MP within 3 months

结局指标

主要结局

visual analogue scale(VAS)

时间窗: baseline as well as 1month, 3 month, 6 months post-injection

VAS is one of the most common tool to assess pain severity for patients, ranging from 0(no pain) to 10(most possible pain).

次要结局

  • cross-sectional area(CSA) of the nerve(baseline as well as 1month, 3 month, 6 months post-injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhu Jiaan

Professor

Peking University People's Hospital

研究点 (1)

Loading locations...

相似试验